U.S. flag

An official website of the United States government

GTR Home > Tests > GIST Profile

Indication

This is a clinical test intended for Help: Prognostic, Therapeutic management

Clinical summary

Help

Imported from OMIM

Gastrointestinal stromal tumors are mesenchymal tumors found in the gastrointestinal tract that originate from the interstitial cells of Cajal, the pacemaker cells that regulate peristalsis in the digestive tract. Approximately 70% of GISTs develop in the stomach, 20% in the small intestine, and less than 10% in the esophagus, colon, and rectum. GISTs are typically more cellular than other gastrointestinal sarcomas. They occur predominantly in patients who are 40 to 70 years old but in rare cases may occur in younger persons (Miettinen et al., 1999, 1999). GISTs are also seen as a feature in several syndromes, e.g., neurofibromatosis-1 (NF1; 162200) and GIST-plus syndrome (175510).

Clinical features

Help

Imported from Human Phenotype Ontology (HPO)

  • Constipation
  • Dysphagia
  • Intestinal obstruction
  • Urticaria
  • Neurofibromatosis
  • Hyperpigmentation of the skin
  • Gastrointestinal stromal tumor
  • Large hands
Show all

Conditions tested

Target population

Help

Patients with Gastrointestinal Stromal Tumors

Citations

Not provided

Clinical validity

Help

Not provided

Clinical utility

Help

Not provided

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.